Avant Immunotherapeutics

BioPhysics Assay Lab Inc., located in Worcester, MA, specializes in the development and commercialization of innovative tools for the life science and biomedical communities. The company offers an array of unique products, including kidney diagnostics, MRI contrast agents, and specialized chemical solutions, aimed at enhancing measurement techniques in various scientific fields. Among its offerings are immunoassay kits for renal function measurement, novel MRI contrast reagents, and pioneering in vivo diagnostic products using neutron activation technology. BioPAL is committed to providing solutions that cater specifically to the needs of researchers and professionals in the life sciences sector. Generated from the website

Cequent Pharmaceuticals, a privately held biopharmaceutical company based in Cambridge, Massachusetts, is at the forefront of developing novel therapeutics aimed at preventing and treating a variety of human diseases, including inflammatory diseases and cancer. Established in 2006, the company leverages its proprietary TransKingdom RNA interference (tkRNAi) technology to target specific disease-causing genes safely and effectively using non-pathogenic bacteria as delivery vehicles. The tkRNAi platform enables the development of drug candidates that can silence one or more cellular genes simultaneously, offering a powerful alternative to traditional small molecules and monoclonal antibodies. With its foundation rooted in groundbreaking scientific research from the Institut Pasteur in Paris and Beth Israel Deaconess Medical Center at Harvard Medical School, Cequent is poised to make significant advancements in the biopharmaceutical landscape. Generated from the website

Nano-C, headquartered in Westwood, MA, was founded by Professor Emeritus Jack B. Howard of MIT, specializing in fullerenic technology known for its energy and environmental efficiency. The company is a leading supplier of fullerenes, fullerene derivatives, and carbon nanotubes, aiming to be at the forefront of producing nanostructured carbon products. Generated from their available business information